ARTICLE | Management Tracks
Hall becomes CEO of Innocoll
Plus: Henderson named CFO at Apogee, and updates from Cerebral and Element
January 27, 2023 12:44 AM UTC
Innocoll Holdings Ltd., a portfolio company of Gurnet Point Capital, hired Kimball Hall as president and CEO. Hall will also serve as CEO of IHL’s two subsidiaries Syntacoll GmbH, a CDMO, and Innocoll Biotherapeutics Inc., a non-opioid pain therapy company. Hall was president, COO and board member at Abzena Ltd. and is a veteran of Genentech Inc., where she was SVP and global head of drug substance manufacturing.
Inflammatory disease company Apogee Therapeutics Inc. hired Jane Henderson as CFO. Henderson was CFO and CBO at Adagio Therapeutics Inc., and CFO at Turnstone Biologics Inc. and Voyager Therapeutics Inc. (NASDAQ:VYGR). Apogee, a Paragon Therapeutics Inc. spinout, raised a $149 million series B round in December...